New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: Prevalence and clinical significance

European Heart Journal

Volumn 30, Issue 24, 2009, Pages 2985-2992

  Pappone, Carlo ^a   Radinovic, Andrea ^a   Manguso, Francesco ^a   Vicedomini, Gabriele ^a   Sala, Simone ^a   Sacco, Francesco Maria ^a   Ciconte, Giuseppe ^a   Saviano, Massimo ^a   Ferrari, Maurizio ^a   Sommariva, Elena ^a   Sacchi, Stefania ^a   Ciaccio, Cristiano ^a   Kallergis, Eleftherios M ^a   Santinelli, Vincenzo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Atrial fibrillation; Brugada syndrome; Sudden cardiac death

Indexed keywords

ANTIARRHYTHMIC AGENT; FLECAINIDE;

ADULT; ARTICLE; BRUGADA SYNDROME; CASE REPORT; DRUG EFFECT; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; GENETIC ANALYSIS; HEART ATRIUM FIBRILLATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL;

ADULT; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; BRUGADA SYNDROME; ELECTROCARDIOGRAPHY; FEMALE; FLECAINIDE; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; MUSCLE PROTEINS; MUTATION; SODIUM CHANNELS;

EID: 72649088295     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp326     Document Type: Article

References (25)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391-1396.
2. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 2003;108:3092-3096.
3. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, Bloise R, Giustetto C, De Nardis R, Grillo M, Ronchetti E, Faggiano G, Nastoli J. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002;105:1342-1347. (Pubitemid 34260426) (Pubitemid 34260426)
4. Eckardt L, Probst V, Smits JP, Bahr ES, Wolpert C, Schimpf R, Wichter T, Boisseau P, Heinecke A, Breithardt G, Borggrefe M, LeMarec H, Böcker D, Wilde AA. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 2005;111:257-263.
5. Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73-78.
6. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005;111:659-670.
7. Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, Corrado D, Hauer RN, Kass RS, Nademanee K, Priori SG, Towbin JA, Study Group on the Molecular Basis of Arrhythmias of the European Society of Cardiology. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation 2002;106:2514-2519. (Pubitemid 35278811) (Pubitemid 35278811)
8. Kusano KF, Taniyama M, Nakamura K, Miura D, Banba K, Nagase S, Morita H, Nishii N, Watanabe A, Tada T, Murakami M, Miyaji K, Hiramatsu S, Nakagawa K, Tanaka M, Miura A, Kimura H, Fuke S, Sumita W, Sakuragi S, Urakawa S, Iwasaki J, Ohe T. Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds. J Am Coll Cardiol 2008;51:1169-1175.
9. Schimpf R, Giustetto C, Eckardt L, Veltmann C, Wolpert C, Gaita F, Breithardt G, Borggrefe M. Prevalence of supraventricular tachyarrhythmias in a cohort of 115 patients with Brugada syndrome. Ann Noninvasive Electrocardiol 2008;13:266-269.
10. Andalib A, Brugada R, Nattel S. Atrial fibrillation: evidence for genetically determined disease. Curr Opin Cardiol 2008;23:176-183.
11. Chen PS, Priori SG. The Brugada syndrome. J Am Coll Cardiol 2008;51:1176-1180.
12. Francis J, Antzelevitch C. Atrial fibrillation and Brugada syndrome. J Am Coll Cardiol 2008;51:1149-1153.
13. Bigi MA, Aslani A, Shahrzad S. Clinical predictors of atrial fibrillation in Brugada syndrome. Europace 2007;9:947-950.
14. Junttila MJ, Raatikainen MJ, Perkiömäki JS, Hong K, Brugada R, Huikuri HV. Familial clustering of lone atrial fibrillation in patients with saddleback-type ST-segment elevation in right precordial leads. Eur Heart J 2007;28:463-468.
15. Yamada T, Watanabe I, Okumura Y, Takagi Y, Okubo K, Hashimoto K, Shindo A, Nakai T, Kasamaki Y, Saito S. Atrial electrophysiological abnormality in patients with Brugada syndrome assessed by P-wave signal-averaged ECG and programmed atrial stimulation. Circ J 2006;70:1574-1579.
16. Bordachar P, Reuter S, Garrigue S, Garrigue S, Cäi X, Hocini M, Jäis P, Häissaguerre M, Clementy J. Incidence, clinical implications and prognosis of atrial arrhythmias in Brugada syndrome. Eur Heart J 2004;25:879-884.
17. Eckardt L, Kirchhof P, Loh P, Schulze-Bahr E, Johna R, Wichter T, Breithardt G, Haverkamp W, Borggrefe M. Brugada syndrome and supraventricular tachyar-rhythmias: a novel association? J Cardiovasc Electrophysiol 2001;12:680-685.
18. Morita H, Kusano-Fukushima K, Nagase S, Fujimoto Y, Hisamatsu K, Fujio H, Haraoka K, Kobayashi M, Morita ST, Nakamura K, Emori T, Matsubara H, Hina K, Kita T, Fukatani M, Ohe T. Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. J Am Coll Cardiol 2002;40:1437-1444.
19. Wolpert C, Echternach C, Veltmann C, Antzelevitch C, Thomas GP, Spehl S, Streitner F, Kuschyk J, Schimpf R, Haase KK, Borggrefe M. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome. Heart Rhythm 2005;2:254-260.
20. Beldner S, Lin D, Marchlinski FE. Flecainide and propafenone induced ST-segment elevation in patients with atrial fibrillation: clue to specificity of Brugada-type elec-trocardiographic changes. Am J Cardiol 2004;94:1184-1185.
21. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Task Force on Practice Guidelines, American College of Cardiology/American Heart Association; Committee for Practice Guidelines, European Society of Cardiology; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 2006;27:1979-2030.
22. Veltmann C, Schimpf R, Echternach C, Eckardt L, Kuschyk J, Streitner F, Spehl S, Borggrefe M, Wolpert C. A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification. Eur Heart J 2006;27:2544-2552.
23. Richter S, Sarkozy A, Veltmann C, Chierchia GB, Boussy T, Wolpert C, Schimpf R, Brugada J, Brugada R, Borggrefe M, Brugada P. Variability of the diagnostic ECG pattern in an ICD patient population with Brugada syndrome. J Cardiovasc Electro-physiol 2009;20:69-75.
24. Schulze-Bahr E, Eckardt L, Breithardt G, Seidl K, Wichter T, Wolpert C, Borggrefe M, Haverkamp W. Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome:different incidences in familial and sporadic disease. Hum Mutat 2003;21:651-652. Erratum in: Hum Mutat 2005;26:61.
25. Alboni P, Botto GL, Baldi N, Luzi M, Russo V, Gianfranchi L, Marchi P, Calzolari M, Solano A, Baroffio R, Gaggioli G. Outpatient treatment of recent-onset atrial fibrillation with the 'pill-in-the-pocket' approach. N Engl J Med 2004;351: 2384-2391.